Granzyme B PET Imaging Drug as a Predictor of Immunotherapy Response to Checkpoint Inhibitors

NCT04169321 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor, Unspecified, Adult
Lymphoma

Interventions

DRUG: Single Arm

Sponsor

Cytosite Biopharma Inc.

Collaborators

[object Object]
[object Object]
[object Object]